Even if it is well known that the TNF-α/IL-23/IL-17 axis is involved in the pathogenesis of psoriasis and PsA [45,46], it is not so easy to compare the efficacy of a selected biologic drug for skin and joints. Here, IL17A is linked to psoriasis.